Study of ARO-CFB in Adult Healthy Volunteers

Summary

The purpose of AROCFB-1001 is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of ARO-CFB Injection in adult healthy volunteers (HVs). HVs will receive either one or two doses of ARO-CFB or placebo.

Timeline

Start

2024-04-05

Primary completion

2025-03-31

Completion

2026-03-06

Drugs

Indications